Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$45,038,693
-$12,463,975 QoQ
Shares Held
356,488
-13.6% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#221
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $812,352,405 across 9 Drug Manufacturers - General names. GILD ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
283,001 | $339,439,917 | |
| 2 | JNJ |
Johnson & Johnson
|
647,222 | $164,374,971 | |
| 3 | ABBV |
AbbVie Inc.
|
399,893 | $100,629,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
650,503 | $83,589,635 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
356,488 | $45,038,693 | |
| 6 | PFE |
Pfizer Inc
|
1,753,548 | $42,225,435 | |
| 7 | AMGN |
Amgen Inc
|
68,480 | $24,797,977 | |
| 8 | BIIB |
Biogen Inc.
|
34,879 | $7,535,956 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,038,693 | 356,488 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $57,502,668 | 412,590 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $27,686,339 | 225,569 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $26,050,590 | 234,690 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $26,030,612 | 234,785 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $26,307,659 | 234,785 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $21,454,872 | 232,271 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $19,473,600 | 232,271 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $16,325,200 | 237,942 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $18,066,746 | 246,645 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $20,480,786 | 252,818 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $19,303,419 | 257,585 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $31,614,730 | 410,208 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $34,025,582 | 410,095 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $37,933,938 | 441,863 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $24,039,174 | 389,677 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $24,062,447 | 389,297 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $22,578,218 | 379,785 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $24,320,864 | 334,952 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $22,626,789 | 323,934 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $20,549,683 | 298,427 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $15,620,360 | 241,689 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $13,733,862 | 235,734 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $15,407,112 | 243,822 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $32,770,361 | 425,921 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $40,555,879 | 542,481 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||